作者
Ketty Peris, Maria Concetta Fargnoli, Claus Garbe, Roland Kaufmann, Lars Bastholt, Nicole Basset Seguin, Veronique Bataille, Veronique Del Marmol, Reinhard Dummer, Catherine A Harwood, Axel Hauschild, Christoph Höller, Merete Haedersdal, Josep Malvehy, Mark R Middleton, Colin A Morton, Eduardo Nagore, Alexander J Stratigos, Rolf-Markus Szeimies, Luca Tagliaferri, Myrto Trakatelli, Iris Zalaudek, Alexander Eggermont, Jean Jacques Grob, European Dermatology Forum EDF, European Association of Dermato-Oncology (EADO
发表日期
2019/9/1
来源
European Journal of cancer
卷号
118
页码范围
10-34
出版商
Pergamon
简介
Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research and Treatment of Cancer collaborated to develop recommendations on diagnosis and treatment of BCC. A new classification into ‘easy-to-treat (common) BCC and ‘difficult-to-treat’ BCC is proposed. Diagnosis is based on clinicodermatoscopic features for ‘easy-to-treat’ BCCs. Histopathological confirmation is mandatory in ambiguous lesions and in BCCs located in high-risk areas. The first-line treatment of ‘easy-to-treat’ BCC is complete surgery. Microscopically controlled surgery shall be offered for high-risk BCC, recurrent BCC and BCC in critical anatomical sites. Topical therapies (5% imiquimod, 5% fluorouracil) and destructive approaches (curettage, electrocautery …
学术搜索中的文章
K Peris, MC Fargnoli, C Garbe, R Kaufmann, L Bastholt… - European Journal of cancer, 2019